Literature DB >> 18256422

Hyper-reactive malarial splenomegaly in a patient with human immunodeficiency virus.

G De Iaco1, N Saleri, F Perandin, M Gulletta, G Ravizzola, N Manca, L Signorini, A Matteelli, K Prestini, F Castelli.   

Abstract

Both hyperreactive malarial splenomegaly (HMS) and HIV infection are highly prevalent in sub-Saharan Africa, but the inter-relationships between the two conditions are not clearly defined. Diagnosis of HMS is particularly difficult in HIV-infected patients, and detection of circulating malaria parasites by polymerase chain reaction (PCR) may represent a useful diagnostic tool.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256422

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  Case Report: Hyperreactive Malarial Splenomegaly Syndrome Diagnosed with Loop-Mediated Isothermal Amplification and Treated with Artemisinin-Based Combination Therapy.

Authors:  Francesco G Genderini; Cecile Haeseleer; Brigitte Cantinieaux; Charlotte Martin
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

2.  Malarial parasite pathogenesis and drug targets.

Authors:  Paul D Roepe
Journal:  F1000 Biol Rep       Date:  2009-02-24

3.  Clinical aspects of uncomplicated and severe malaria.

Authors:  Alessandro Bartoloni; Lorenzo Zammarchi
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-04       Impact factor: 2.576

Review 4.  The hyper-reactive malarial splenomegaly: a systematic review of the literature.

Authors:  Stefania Leoni; Dora Buonfrate; Andrea Angheben; Federico Gobbi; Zeno Bisoffi
Journal:  Malar J       Date:  2015-04-29       Impact factor: 2.979

5.  Hyperreactive Malarious Splenomegaly and AIDS: a case report.

Authors:  Zuleica Naomi Tano; Chafic Esper Kallas Filho; Regina Mitsuka Breganó; Wander Rogério Pavanelli; Uheyna Gancedo Ruzon
Journal:  Braz J Infect Dis       Date:  2014-06-06       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.